So . . . I just talked with Patrick at Investor Relations. He really is a nice guy. I expressed our concerns on why ONCS has not issued a PR regarding ASGCT. He agreed that ASGCT is fundamentally different than ASCO and that the privacy concerns are not the same. He also said that several people have inquired with the same question. I explained that from my perspective getting the word out about a scientific conference is fundamentally different than information that ONCS is presenting at an investor conference. He agreed. He said he would take my concerns and the concerns of other fellow board members and pass it along to management. We'll see.
Market Data 
Markets 
AI
